Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 813 of 1,261
  1. US 8734527

    Encapsulated kidney tissue

    Advanced Technologies and Regenerative Medicine, LLC · Granted May 27, 2014 · Expires May 22, 2034

    granted
  2. US 8735414

    Indole derivatives and methods for antiviral treatment

    PTC THERAPEUTICS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  3. US 8734836

    Methods and compositions for applying pharmacologic agents to the ear

    Regents of the University of Minnesota · Granted May 27, 2014 · Expires May 22, 2034

    granted
  4. US 8735566

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 27, 2014 · Expires May 22, 2034

    granted
  5. US 8734786

    Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection

    Northwestern University · Granted May 27, 2014 · Expires May 22, 2034

    granted
  6. US 8735066

    Tumor suppressor designated TS10Q23.3

    The Board of Regents of the University of Texas System · Granted May 27, 2014 · Expires May 22, 2034

    granted
  7. US 8735082

    Gene signature for predicting prognosis of patients with solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  8. US 8735126

    Disease control with tick phospholipase A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  9. US 8735153

    Modulation of stem cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  10. US 8735095

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  11. US 8735075

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted May 27, 2014 · Expires May 22, 2034

    granted
  12. US 8734778

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted May 27, 2014 · Expires May 22, 2034

    granted
  13. US 8735358

    Methods for treating cancer by regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted May 27, 2014 · Expires May 22, 2034

    granted
  14. US 8735382

    Infusion and injection solution of levodopa

    Dizlin Medical Design AB · Granted May 27, 2014 · Expires May 22, 2034

    granted
  15. US 8735392

    Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt

    BIOMARIN PHARMACEUTICAL INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  16. US 8735355

    Methods of use of fragments of secreted frizzled related protein, sFRP

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  17. US 8735407

    Purine derivatives as A3 adenosine receptor-selective agonists

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  18. US 8735408

    Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

    LEXICON PHARMACEUTICALS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  19. US 8735400

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  20. US 8735401

    Thienopyrimidine compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 27, 2014 · Expires May 22, 2034

    granted
  21. US 8735418

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  22. US 8734930

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted May 27, 2014 · Expires May 22, 2034

    granted
  23. US 8734853

    HDL particles for delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted May 27, 2014 · Expires May 22, 2034

    granted
  24. US 8734825

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted May 27, 2014 · Expires May 22, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.